- Home
- CARM vs SURG Comparison
CARM vs SURG Comparison
Compare CARM & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- SURG
- Stock Information
- Founded
- CARM 2016
- SURG 2006
- Country
- CARM United States
- SURG United States
- Employees
- CARM N/A
- SURG N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- SURG Advertising
- Sector
- CARM Health Care
- SURG Consumer Discretionary
- Exchange
- CARM Nasdaq
- SURG Nasdaq
- Market Cap
- CARM 35.5M
- SURG 32.4M
- IPO Year
- CARM N/A
- SURG N/A
- Fundamental
- Price
- CARM $0.47
- SURG $1.82
- Analyst Decision
- CARM Hold
- SURG Buy
- Analyst Count
- CARM 5
- SURG 2
- Target Price
- CARM $4.57
- SURG $8.50
- AVG Volume (30 Days)
- CARM 329.1K
- SURG 1.3M
- Earning Date
- CARM 11-07-2024
- SURG 11-12-2024
- Dividend Yield
- CARM N/A
- SURG N/A
- EPS Growth
- CARM N/A
- SURG N/A
- EPS
- CARM N/A
- SURG N/A
- Revenue
- CARM $20,268,000.00
- SURG $83,602,653.00
- Revenue This Year
- CARM $46.34
- SURG N/A
- Revenue Next Year
- CARM N/A
- SURG $56.47
- P/E Ratio
- CARM N/A
- SURG N/A
- Revenue Growth
- CARM 41.13
- SURG N/A
- 52 Week Low
- CARM $0.38
- SURG $1.33
- 52 Week High
- CARM $3.16
- SURG $9.23
- Technical
- Relative Strength Index (RSI)
- CARM 21.83
- SURG 50.61
- Support Level
- CARM $0.38
- SURG $1.70
- Resistance Level
- CARM $0.82
- SURG $1.90
- Average True Range (ATR)
- CARM 0.06
- SURG 0.12
- MACD
- CARM -0.03
- SURG -0.01
- Stochastic Oscillator
- CARM 18.22
- SURG 31.89
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.